Kintara Therapeutics, Inc.(KTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KTRA Kintara Therapeutics, Inc.

休市中 05-03 16:00:00 EDT

0.1513

-0.0059

-3.75%

盘后0.1513

+0.00000.00%

19:59 EDT

最高0.1624	最低0.1499	成交量304.36万
今开0.1565	昨收0.1572	日振幅7.95%
总市值590.64万	流通市值590.47万	总股本3,904万
成交额47.60万	换手率7.80%	流通股本3,903万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KTRA","market":"US","secType":"STK","nameCN":"Kintara Therapeutics, Inc.","latestPrice":0.1513,"timestamp":1714766400000,"preClose":0.1572,"halted":0,"volume":3043582,"hourTrading":{"tag":"盘后","latestPrice":0.1513,"preClose":0.1513,"latestTime":"19:59 EDT","volume":265654,"amount":39804.322138,"timestamp":1714780778392},"delay":0,"floatShares":39026300,"shares":39037900,"eps":-4.568215,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0059,"latestTime":"05-03 16:00:00 EDT","open":0.1565,"high":0.1624,"low":0.1499,"amount":476035.21675168,"amplitude":0.079517,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.568215,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"adjPreClose":0.1572,"preHourTrading":{"tag":"盘前","latestPrice":0.1515,"preClose":0.1572,"latestTime":"09:26 EDT","volume":65408,"amount":9840.54726144,"timestamp":1714742786460},"postHourTrading":{"tag":"盘后","latestPrice":0.1513,"preClose":0.1513,"latestTime":"19:59 EDT","volume":265654,"amount":39804.322138,"timestamp":1714780778392},"volumeRatio":0.21502477701666892},"requestUrl":"/m/hq/s/KTRA","defaultTab":"news","newsList":[{"id":"2431324172","title":"Kintara Therapeutics, Inc.盘中异动 急速下挫6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431324172","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431324172?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:47","pubTimestamp":1714484835,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时47分，Kintara Therapeutics, Inc.股票出现异动，股价快速下跌6.40%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cyclacel Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为611.18%、190.76%、10.94%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Senti Biosciences, Inc.、Vaxxinity, Inc.，振幅分别为46.79%、24.41%、23.00%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302147167a57c188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302147167a57c188&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430727717","title":"Kintara Therapeutics, Inc.股价拉升20.44% 市值涨151.85万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430727717","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430727717?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:32","pubTimestamp":1714138359,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时32分，Kintara Therapeutics, Inc.股票出现异动，股价大幅拉升20.44%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Tevogen Bio Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为585.22%、68.61%、20.73%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为34.80%、31.73%、24.13%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621323987b3f235&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621323987b3f235&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428652448","title":"Kintara Therapeutics, Inc.盘中异动 快速拉升10.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428652448","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428652448?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:31","pubTimestamp":1713533483,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时31分，Kintara Therapeutics, Inc.股票出现异动，股价快速上涨10.41%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Portage Biotech Inc.、Chromocell Therapeutics Corporation涨幅较大，Bio-Path Holdings, Inc.、Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为89.81%、3.42%、2.76%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Tiziana Life Sciences Ltd、Vigil Neuroscience, Inc.，振幅分别为14.19%、9.70%、9.45%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。这两个项目是用于 GBM 的 VAL-083 和用于 CMBC 的 REM-001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192131238b3b4b87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192131238b3b4b87&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427247875","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427247875","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427247875?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:24","pubTimestamp":1713277463,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日22时24分，Kintara Therapeutics, Inc.股票出现异动，股价大幅跳水5.27%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Jaguar Health, Inc.、Palisade Bio, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Palisade Bio, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为2229.97%、120.95%、109.48%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.、Palisade Bio, Inc.，振幅分别为101.94%、97.81%、71.15%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622242387e80fea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622242387e80fea&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427900006","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大跌7.83%报0.115美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427900006","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427900006?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:37","pubTimestamp":1713188243,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时37分，Kintara Therapeutics, Inc.股票出现波动，股价大幅下跌7.83%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Longeveron Inc.、Organovo Holdings, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Longeveron Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为630.88%、309.09%、300.58%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Psyence Biomedical Ltd C/Wts 25/01/2029、Organovo Holdings, Inc.，振幅分别为50.52%、40.35%、34.65%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。这两个项目是用于 GBM 的 VAL-083 和用于 CMBC 的 REM-001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152137237a52d9f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152137237a52d9f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426738149","title":"Kintara Therapeutics, Inc.盘中异动 快速跳水5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426738149","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426738149?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:53","pubTimestamp":1712929996,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时53分，Kintara Therapeutics, Inc.股票出现异动，股价快速下跌5.32%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为2337.67%、837.81%、38.32%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、Qualigen Therapeutics, Inc.，振幅分别为69.81%、60.95%、17.87%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。这两个项目是用于 GBM 的 VAL-083 和用于 CMBC 的 REM-001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122153167a527604&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122153167a527604&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424084546","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大涨116.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424084546","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424084546?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:31","pubTimestamp":1712151063,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时31分，Kintara Therapeutics, Inc.股票出现异动，股价急速上涨116.93%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Kintara Therapeutics, Inc.、方舟生物医药、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Addex Therapeutics Limited较为活跃，换手率分别为225.19%、62.69%、16.06%，振幅较大的相关个股有Kintara Therapeutics, Inc.、居里、Atai Life Sciences N.V.，振幅分别为11.65%、9.09%、7.49%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131048aed960f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131048aed960f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424814516","title":"BUZZ-Kintara Therapeutics加倍推进与TuHURA Biosciences的合并计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2424814516","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424814516?lang=zh_cn&edition=full","pubTime":"2024-04-03 20:03","pubTimestamp":1712145784,"startTime":"0","endTime":"0","summary":"    4月3日 - ** Kintara Therapeutics   股价盘前翻了一番多，达到0.21美元 ** 公司将把  与私人控股的 TuHURA Biosciences 合并，预计合并将在第三季度完成** 预计 KTRA 股东将合计拥有约 2.85% 的股份，如果达到某些里程碑，则将拥有约 5.45% 的股份，而 TuHURA 股东将合计拥有约 97.15%的股份，如果达到里程碑，则将拥有 94.55% 的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472210","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大跌5.42%报0.089美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472210","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420472210?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:30","pubTimestamp":1710768624,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时30分，Kintara Therapeutics, Inc.股票出现异动，股价快速下跌5.42%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Xtl生物制药、2Seventy Bio, Inc.、Iterum Therapeutics Plc涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Silo Pharma, Inc.较为活跃，换手率分别为57.41%、11.42%、5.35%，振幅较大的相关个股有Scorpius Holdings, Inc.、Ibio, Inc.、Abeona Therapeutics Inc.，振幅分别为5.95%、5.71%、5.33%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213024861df15d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213024861df15d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419703719","title":"Kintara Therapeutics, Inc.盘中异动 早盘急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419703719","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419703719?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:07","pubTimestamp":1710511656,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时07分，Kintara Therapeutics, Inc.股票出现波动，股价大幅跳水5.09%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Better Therapeutics, Inc.、杰龙、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为210.96%、71.63%、17.34%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物，振幅分别为94.29%、63.00%、49.00%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315220736861deaf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315220736861deaf4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419601780","title":"Kintara Therapeutics, Inc.盘中异动 早盘快速跳水13.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419601780","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419601780?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:31","pubTimestamp":1710423100,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时31分，Kintara Therapeutics, Inc.股票出现异动，股价急速下跌13.68%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，知临集团、180 Life Sciences Corp C/Wts 07/11/2025、Nuvectis Pharma, Inc.涨幅较大，Novabay Pharmaceuticals, Inc.、知临集团、Gri Bio, Inc.较为活跃，换手率分别为115.82%、59.03%、58.29%，振幅较大的相关个股有知临集团、Renovorx, Inc.、Codexis, Inc.，振幅分别为16.17%、14.40%、8.58%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142131408b32f49a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142131408b32f49a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419682773","title":"Kintara Therapeutics, Inc.股价上涨41.15% 市值涨189.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419682773","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419682773?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:32","pubTimestamp":1710336757,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时32分，Kintara Therapeutics, Inc.股票出现波动，股价大幅拉升41.15%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Nucana Plc、Kintara Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Revelation Biosciences, Inc.较为活跃，换手率分别为93.17%、38.32%、14.66%，振幅较大的相关个股有Nucana Plc、Kintara Therapeutics, Inc.、Cybin Inc.，振幅分别为18.20%、17.94%、16.14%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132132378b2e217b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132132378b2e217b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415264395","title":"Kintara Therapeutics, Inc.盘中异动 大幅拉升8.09%报0.110美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415264395","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415264395?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:32","pubTimestamp":1709217135,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时32分，Kintara Therapeutics, Inc.股票出现异动，股价大幅拉升8.09%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Enveric Biosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Avidity Biosciences, Inc.涨幅较大，Enveric Biosciences, Inc.、Scisparc Ltd.、Neurobo Pharmaceuticals, Inc.较为活跃，换手率分别为1719.00%、52.62%、49.57%，振幅较大的相关个股有Enveric Biosciences, Inc.、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Atara Biotherapeutics, Inc.，振幅分别为33.69%、15.55%、15.35%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。这两个项目是用于 GBM 的 VAL-083 和用于 CMBC 的 REM-001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292232158af0be03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292232158af0be03&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414870833","title":"Kintara Therapeutics Inc盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414870833","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414870833?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:30","pubTimestamp":1708957844,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时30分，Kintara Therapeutics Inc股票出现异动，股价大幅上涨5.26%。Kintara Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Zyversa Therapeutics Inc、Ocean Biomedical Inc C/Wts 14/02/2028 、Portage Biotech Inc涨幅较大，Zyversa Therapeutics Inc、Lixte Biotechnology Holdings  Inc、Neubase Therapeutics Inc较为活跃，换手率分别为567.89%、56.94%、43.32%，振幅较大的相关个股有Aeon Biopharma Inc、Ibio Inc、Coeptis Therapeutics Holdings Inc，振幅分别为4.30%、4.17%、4.03%。Kintara Therapeutics Inc公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262230447914b1ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262230447914b1ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413177512","title":"Kintara Therapeutics Inc盘中异动 股价大跌5.02%报0.089美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413177512","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413177512?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:00","pubTimestamp":1708614025,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日23时00分，Kintara Therapeutics Inc股票出现波动，股价大幅跳水5.02%。截至发稿，该股报0.089美元/股，成交量305.849万股，换手率7.83%，振幅4.06%。Kintara Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.86%。Kintara Therapeutics Inc公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222230025791383c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222230025791383c5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412510386","title":"Kintara Therapeutics Inc盘中异动 早盘股价大涨30.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412510386","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412510386?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:32","pubTimestamp":1708439551,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日22时32分，Kintara Therapeutics Inc股票出现波动，股价快速拉升30.00%。Kintara Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Monopar Therapeutics Inc、Scisparc Ltd、Dermata Therapeutics Inc C/Wts 13/08/2026 涨幅较大，Scisparc Ltd、Clearmind Medicine Inc、Monopar Therapeutics Inc较为活跃，换手率分别为1572.75%、278.01%、214.57%，振幅较大的相关个股有Monopar Therapeutics Inc、Scisparc Ltd、Better Therapeutics Inc，振幅分别为43.78%、27.30%、18.31%。Kintara Therapeutics Inc公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。这两个项目是用于 GBM 的 VAL-083 和用于 CMBC 的 REM-001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022323181a00d93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022323181a00d93&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411350777","title":"Kintara Therapeutics Inc盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411350777","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411350777?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:36","pubTimestamp":1707835008,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时36分，Kintara Therapeutics Inc股票出现波动，股价大幅下挫5.08%。Kintara Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、联拓生物涨幅较大，Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃，换手率分别为303.81%、86.77%、37.74%，振幅较大的相关个股有Adial Pharmaceuticals Inc、Kalvista Pharmaceuticals Inc、Fresh2 Group Limited，振幅分别为15.91%、15.02%、13.77%。Kintara Therapeutics Inc公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。这两个项目是用于 GBM 的 VAL-083 和用于 CMBC 的 REM-001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402132236487a4377c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402132236487a4377c0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410701840","title":"Kintara Therapeutics Inc盘中异动 股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410701840","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410701840?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:31","pubTimestamp":1707748300,"startTime":"0","endTime":"0","summary":"北京时间2024年02月12日22时31分，Kintara Therapeutics Inc股票出现波动，股价快速拉升5.30%。Kintara Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Revelation Biosciences Inc C/Wts 10/01/2027 、Cymabay Therapeutics Inc涨幅较大，Kintara Therapeutics Inc、Tc Biopharm  Plc、Cymabay Therapeutics Inc较为活跃，换手率分别为90.20%、48.04%、13.97%，振幅较大的相关个股有Intensity Therapeutics Inc、依生生物、Sonnet Biotherapeutics Hldgs Inc，振幅分别为10.56%、9.55%、9.26%。Kintara Therapeutics Inc公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402122231408185fec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402122231408185fec2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407612693","title":"Kintara Therapeutics Inc盘中异动 股价大跌5.00%报0.122美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407612693","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407612693?lang=zh_cn&edition=full","pubTime":"2024-01-31 00:06","pubTimestamp":1706630814,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日00时06分，Kintara Therapeutics Inc股票出现波动，股价快速下跌5.00%。Kintara Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Neximmune Inc、Pepgen Inc、Psyence Biomedical Ltd涨幅较大，Neximmune Inc、Panbela Therapeutics Inc、Iterum Therapeutics Plc较为活跃，换手率分别为812.74%、220.11%、163.50%，振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Pepgen Inc，振幅分别为800.00%、157.42%、61.72%。Kintara Therapeutics Inc公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131000654861cefef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131000654861cefef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407624098","title":"Kintara Therapeutics Inc盘中异动 大幅下跌6.15%报0.125美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407624098","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407624098?lang=zh_cn&edition=full","pubTime":"2024-01-29 22:30","pubTimestamp":1706538646,"startTime":"0","endTime":"0","summary":"北京时间2024年01月29日22时30分，Kintara Therapeutics Inc股票出现异动，股价快速跳水6.15%。Kintara Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Palisade Bio Inc、Revelation Biosciences Inc、Novabay Pharmaceuticals Inc涨幅较大，Revelation Biosciences Inc、Panbela Therapeutics Inc、Novabay Pharmaceuticals Inc较为活跃，换手率分别为630.69%、489.81%、374.52%，振幅较大的相关个股有Conduit Pharmaceuticals Inc、Bio-Path Holdings Inc、Gamida Cell Ltd，振幅分别为14.21%、8.04%、7.14%。Kintara Therapeutics Inc公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401292230467a3f4e51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401292230467a3f4e51&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintara.com","stockEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":-0.0774},{"period":"3month","weight":0.2114},{"period":"6month","weight":-0.6561},{"period":"1year","weight":-0.9631},{"period":"ytd","weight":-0.1079}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kintara Therapeutics, Inc.是一家内华达州公司，成立于2009年6月24日，名称为Berry Only，Inc。该公司是一家临床阶段的生物制药公司。Kintara致力于为医疗需求未得到满足的患者开发新型癌症疗法。Kintara公司正在开发两种晚期疗法，以降低风险，满足明确的未满足的医疗需求。这两个项目分别是VAL-083治疗胶质母细胞瘤（GBM）和REM-001治疗皮肤转移性乳腺癌（CMBC）。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.077817},{"month":2,"riseRate":0.125,"avgChangeRate":-0.104771},{"month":3,"riseRate":0.25,"avgChangeRate":-0.042889},{"month":4,"riseRate":0.25,"avgChangeRate":-0.056005},{"month":5,"riseRate":0.5,"avgChangeRate":1.243665},{"month":6,"riseRate":0.571429,"avgChangeRate":0.005167},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.009225},{"month":8,"riseRate":0.5,"avgChangeRate":-0.099143},{"month":9,"riseRate":0.25,"avgChangeRate":-0.124445},{"month":10,"riseRate":0.375,"avgChangeRate":-0.127831},{"month":11,"riseRate":0.375,"avgChangeRate":-0.094725},{"month":12,"riseRate":0.25,"avgChangeRate":-0.134944}],"exchange":"NASDAQ","name":"Kintara Therapeutics, Inc.","nameEN":"Kintara Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kintara Therapeutics, Inc.(KTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kintara Therapeutics, Inc.(KTRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kintara Therapeutics, Inc.,KTRA,Kintara Therapeutics, Inc.股票,Kintara Therapeutics, Inc.股票老虎,Kintara Therapeutics, Inc.股票老虎国际,Kintara Therapeutics, Inc.行情,Kintara Therapeutics, Inc.股票行情,Kintara Therapeutics, Inc.股价,Kintara Therapeutics, Inc.股市,Kintara Therapeutics, Inc.股票价格,Kintara Therapeutics, Inc.股票交易,Kintara Therapeutics, Inc.股票购买,Kintara Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kintara Therapeutics, Inc.(KTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kintara Therapeutics, Inc.(KTRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况